Bastide Le Confort Médical stock | 2026 earnings growth & current analysis

Bastide Le Confort M...

ENXTPA:BLC

€ 23,05

€-0,75 (-3,15%)

23,05 €

€-0,75 (-3,15%)

End-of-day quote: 03/26/2026

Bastide Le Confort Médical Stock Value

Analysts currently rate ENXTPA:BLC as Buy.

Buy

Bastide Le Confort Médical Company Info

EPS Growth 5Y

-9,46%

Market Cap

€0,17 B

Long-Term Debt

€0,34 B

Quarterly earnings

N/A

Dividend

€0,00

Dividend Yield

0,00%

Founded

1977

Industry

Health Care

Country

France

Website

Bastide Le Confort Médical

ISIN Number

FR0000035370

Website

http://www.bastideleconfortmedical.com

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

€37,00

60.52%

Last Update: 03/22/2026

Analysts: 2

Highest Price Target €43,00

Average Price Target €37,00

Lowest Price Target €31,00

In the last five quarters, Bastide Le Confort Médical’s Price Target has risen from €24,60 to €30,17 - a 22,64% increase. Two analysts predict that Bastide Le Confort Médical’s share price will increase in the coming year, reaching €37,00. This would represent an increase of 60,52%.

Top growth stocks in the health care sector (5Y.)

What does Bastide Le Confort Médical do?

Bastide Le Confort Médical SA provides medical equipment and solutions. Business Segments The company operates through business segments: respiratory therapy, nutrition, perfusion, stomatherapy, and urology. Respiratory Therapy This segment provides advanced solutions for patients with chronic respiratory diseases. These solutions help improve the quality of life for patients through effective management of their conditions. The company invests heavily in research and development to ensure t...

Bastide Le Confort Médical SA provides medical equipment and solutions.

Business Segments

The company operates through business segments: respiratory therapy, nutrition, perfusion, stomatherapy, and urology.

Respiratory Therapy

This segment provides advanced solutions for patients with chronic respiratory diseases. These solutions help improve the quality of life for patients through effective management of their conditions. The company invests heavily in research and development to ensure that it remains at the forefront of innovation in respiratory care, allowing for the introduction of cutting-edge technologies.

Nutrition

This segment emphasizes the importance of personalized nutrition for patients, particularly those needing enteral nutrition. The company provides tailored nutritional solutions, ensuring patients receive the appropriate nutrients required for recovery and overall health maintenance.

Perfusion

This segment focuses on the safe and effective administration of intravenous therapies. This segment addresses critical health issues requiring rapid and precise treatment, highlighting the importance of reliable delivery systems that enhance patient outcomes.

Stomatherapy

This segment specializes in products that assist patients with stomas, ensuring comfort and quality of life through suitable products. The company is dedicated to continuously improving these offerings by integrating feedback from healthcare professionals and patients.

Urology

This segment offers a range of products designed to assist with various urological conditions, including incontinence issues. This segment underscores the company’s commitment to addressing diverse healthcare needs through innovative medical solutions.

Business Strategy

The company employs a robust business strategy focused on organic growth while remaining open to acquisition opportunities. The company has set a clear revenue target for the upcoming fiscal year, indicating optimistic expectations for continued performance in its core segments, particularly respiratory therapy and nutrition.

The company is aware of the increasing regulatory and operational challenges within the healthcare sector and emphasizes strict control over operating costs. By prioritizing the expansion of technical business activities, the company aims to enhance profitability while managing resources efficiently.

The company’s strategy focuses on operational transparency and maintaining stakeholder engagement. By focusing on its operating cash flow and managing working capital effectively, the company aims to achieve a high recurring operating margin.

Additionally, the company seeks to reduce debt levels to solidify its financial standing, which is integral to securing future growth. The strategy emphasizes maintaining a balance between operational independence and market expansion, ensuring that growth initiatives align with the company’s overarching mission to improve patient care.

Products and Services

The company offers a diverse array of products and services designed to meet the medical needs of patients across various segments. In respiratory therapy, the company provides high-quality medical devices and accessories that assist in managing chronic conditions such as sleep apnea and COPD (Chronic Obstructive Pulmonary Disease).

Furthermore, the nutrition and perfusion services include customized nutritional solutions and intravenous therapy systems, ensuring that patients receive optimal care during treatment. The stomatherapy offerings focus on specialized products that provide comfort and security for patients living with stomas.

In the urology domain, the company supplies innovative solutions for incontinence and other urological conditions, catering to a significant patient demographic.

Geographical Markets Served

The company operates primarily in the French market while also engaging in international expansion initiatives. The company's strategic growth plans encompass consolidating its presence in Europe and seeking opportunities in emerging markets.

Customers

The company serves a diverse customer base that includes hospitals, clinics, healthcare providers, and individual patients.

Modes of Sales and Marketing/Marketing/Distribution Channels

The company employs a multi-faceted sales and marketing strategy that encompasses direct sales, partnerships with healthcare providers, and distribution through established channels. The company prioritizes building relationships with healthcare practitioners to ensure that products are effectively integrated into patient care.

History

Bastide Le Confort Médical SA was founded in 1977.

New support ticket

Explore

Bastide Le Confort Médical Stock Value

Bastide Le Confort Médical Company Info

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does Bastide Le Confort Médical do?

Offer & Services

Service & Collaboration

Company & Legal

New support ticket

Explore

Bastide Le Confort Médical Stock Value

Bastide Le Confort Médical Company Info

Analyst Price Target The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does Bastide Le Confort Médical do?

Offer & Services

Service & Collaboration

Company & Legal

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.